Prospect Financial Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Prospect Financial Group's LLY Position: Q1 2026 in Review
Prospect Financial Group reduced its Eli Lilly (LLY) stake by 5.3% in Q1 2026, selling an estimated $29.4K and leaving 519 shares worth $477K. The position accounts for 0.44% of the portfolio, ranked #39.
Prospect Financial Group first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $589K in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Prospect Financial Group held 519 shares of Eli Lilly worth $477K as of Q1 2026.
- Prospect Financial Group sold 29 Eli Lilly shares in Q1 2026, an estimated $29.4K.
- Eli Lilly made up 0.44% of Prospect Financial Group's portfolio in Q1 2026, its #39 holding.
- Prospect Financial Group first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
- Prospect Financial Group's Eli Lilly position peaked at $589K in Q4 2025.
- 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Prospect Financial Group's 13F filing for Q1 2026, filed 6 May 2026.